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Abstract
Background: Musculocontractural Ehlers–Danlos Syndrome (mcEDS) is a rare 
connective tissue disorder caused by biallelic loss-of-function variants in CHST14 
(mcEDS-CHST14) or DSE (mcEDS-DSE), both of which result in defective derma-
tan sulfate biosynthesis. Forty-one patients with mcEDS-CHST14 and three patients 
with mcEDS-DSE have been described in the literature.
Methods: Clinical, molecular, and glycobiological findings in three additional pa-
tients with mcEDS-DSE were investigated.
Results: Three patients from two families shared craniofacial characteristics (hyper-
telorism, blue sclera, midfacial hypoplasia), skeletal features (pectus and spinal de-
formities, characteristic finger shapes, progressive talipes deformities), skin features 
(fine or acrogeria-like palmar creases), and ocular refractive errors. Homozygous 
pathogenic variants in DSE were found: c.960T>A/p.Tyr320* in patient 1 and 
c.996dupT/p.Val333Cysfs*4 in patients 2 and 3. No dermatan sulfate was detected 
in the urine sample from patient 1, suggesting a complete depletion of DS.
Conclusion: McEDS-DSE is a congenital multisystem disorder with progressive 
symptoms involving craniofacial, skeletal, cutaneous, and cardiovascular systems, 
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1 |  INTRODUCTION
Musculocontractural Ehlers–Danlos Syndrome (mcEDS) 
is a rare connective tissue disorder, caused by biallelic 
loss-of-function variants in CHST14 (mcEDS-CHST14) 
(MIM#601776) or in DSE (mcEDS-DSE) (MIM#615539), 
both of which result in defective dermatan sulfate (DS) biosyn-
thesis (Brady, Demirdas, & Fournel-Gigleux, 2017; Malfait, 
Francomano, & Byers, 2017). Hallmarks of mcEDS include 
altered craniofacial features, multiple congenital contractures 
(e.g., adducted thumbs, talipes equinovarus), characteristic 
fine palmar creases, peculiar finger shapes, progressive spi-
nal and foot deformities, large subcutaneous hematomas, and 
ophthalmological and urogenital involvement (Brady et al., 
2017). Only five patients with mcEDS-DSE have been de-
scribed in the literature (Müller, Mizumoto, & Suresh, 2013; 
Schirwani et al., 2019; Syx, Van Damme, & Symoens, 2015) 
in contrast to 41 patients with mcEDS-CHST14 (Brady et al., 
2017; Kono, Hasegawa-Murakami, & Sugiura, 2016; Sandal 
& Kaur, 2018). Here, we report detailed clinical, molecular, 
and glycobiological findings in three additional patients with 
mcEDS-DSE.
2 |  CLINICAL REPORT
Patient 1, a 19-year-old man and average high school student, 
was born of consanguineous Turkish parents. Pregnancy was 
complicated by premature rupture of membranes and he was 
delivered by emergency cesarean section at gestational week 
29. At birth, he exhibited cyanosis and bradycardia with 
Apgar scores of 7 at 1 min and 10 at 5 min. His birth weight 
was 1,215 g (−1 standard deviation [SD]), length was 35 cm 
(−3 SDs), and occipitofrontal circumference (OFC) was 
26.7 cm (−0.5 SD).
In infancy to early childhood, he exhibited large anterior 
fontanel, brachycephaly, low hairline, wide neck, hyper-
telorism, blue sclera, short nose with hypoplastic columella, 
long philtrum, and thin upper lip vermilion. He had bilateral 
adducted thumbs, arachnodactyly, and rocker bottom feet, but 
did not exhibit talipes equinovarus. He had umbilical hernia, 
diastasis recti, bilateral hydronephrosis, and cryptorchidism. 
He experienced recurrent constipation, which was treated 
with laxatives. Echocardiography revealed an atrial septal de-
fect and patent ductus arteriosus. He exhibited delayed motor 
development and mild hypotonia; he sat without support at 
age 8 months and walked unassisted at 18 months. He un-
derwent surgeries for strabismus and cryptorchidism at 3 and 
5 years of age, respectively.
At 8  years of age, brain magnetic resonance imaging 
showed cortical heterotopia. He was diagnosed with myopia 
and strabismus, and later diagnosed with unilateral 40  dB 
high-frequency sensorineural hearing loss. During his school 
years, he experienced repeated shoulder luxation and large 
subcutaneous hematomas at various locations (each ante-
brachium and the gluteal region) after minor traumas and 
without the evidence of coagulation defects. He had mild sco-
liosis and joint hypermobility, and underwent surgery for pes 
cavus at 11 years of age. His skin was hyperextensible with 
delayed wound healing. At 15 years of age, he had a self-lim-
iting hemoptysis with no evidence of tuberculosis.
At 18 years of age, his height was 178 cm (−0.2 SD), 
weight was 77  kg (+0.5 SD), and OFC was 58  cm (+2 
SDs). He had downslanting palpebral fissures, grey sclera, 
but no hypertelorism. His ears were not rotated or low-set; 
however, his right ear showed underfolded helix, lower in-
sertion of the lobule than on the left side, and pits on the 
posterior conchae. He had dental crowding, and his skin 
was hyperextensible, with fine palmar (Figure 1b) and 
solar creases, and broadened surgical scars on the right 
foot (Figure 1d). His fingers were long and slender with 
joint laxity and a swan-neck deformity, as well as the radial 
deviation of the bilateral second to fourth fingers (Figure 
1a). He had bilateral pes cavus (Figure 1e), mild pectus 
excavatum (Figure 1c), and lumbar scoliosis. He had no 
echocardiographic abnormalities, but was diagnosed with 
high blood pressure and treated with an angiotensin-con-
verting enzyme inhibitor.
Patient 2, a 14-year-old girl and average student, was born 
of consanguineous Indian parents. After an uncomplicated 
pregnancy, she had been delivered vaginally at term with a 
birth weight of 2.5 kg; she had normal developmental mile-
stones. She experienced intermittent joint pain and swelling 
after exercise (left knee and right ankle) and exhibited sco-
liosis at 11  years of age. She had astigmatism, but normal 
hearing.
At 12.5  years of age, her height was 141  cm, weight 
was 27.9 kg, and OFC was 48 cm (all below the third cen-
tile). She had hypertelorism, blue sclera, and a broad tall 
nasal bridge; she had no skin hyperextensibility or appar-
ent scars. Her fingers and toes were long with mild fin-
ger webbing (Figure 1f,h), and crisscrossing palmar and 
similar to the symptoms of mcEDS-CHST14. However, the burden of symptoms 
seems lower in patients with mcEDS-DSE.
K E Y W O R D S
clinical features, delineation, dermatan sulfate, musculocontractural EDS-DSE
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F I G U R E  1  Clinical photographs of patient 1 at 18 years of age (a−e), patient 2 at 12.5 years of age (f−h), and patient 3 at 21 years of age (i−m)
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solar creases (Figure 1g). Joint laxity was limited to the 
dorsal subluxation of the metacarpophalangeal joints, es-
pecially the thumbs. Her chest was asymmetric with pectus 
carinatum and she had thoracic kyphoscoliosis. Her bone 
mineral density, measured by dual-energy X-ray absorpti-
ometry, was reduced to 0.659  g/cm2 at the lumbar spine 
(normal range for 20-year-old women, 0.8−1.2 g/cm2), and 
0.513 g/cm2 at the femoral neck (normal range for 20-year-
old women, 0.6−1.0 g/cm2). She had no echocardiographic 
abnormalities or muscle weakness.
Patient 3, a 22-year-old man and the older brother of 
patient 2, was born at term after an uncomplicated preg-
nancy, with a birth weight of 2.9 kg. He had bilateral tali-
pes equinovarus, which was treated with serial casting and 
surgical correction at 1 year of age. His early psychomotor 
development was normal. He experienced right arm frac-
ture after a fall at 4 years of age and right fifth finger frac-
ture at 7 years of age. He developed a large subcutaneous 
hematoma in his left calf twice, both requiring surgical 
evacuation. He also had intermittent bruises over his shins. 
He exhibited scoliosis at 14 years of age, which progressed 
and required surgical correction at 20 years of age. He had 
myopia, but normal hearing. He attended a normal school, 
but did not perform well.
At 21 years of age, his height was 151 cm and weight 
was 40 kg (both below the third centile). He had small sim-
ple ears, mild hypertelorism, blue sclera, a broad tall nasal 
bridge (Figure 1i), and retained primary teeth. Atrophic 
surgical scars, finger webbing, and abnormal palmar 
(Figure 1j,k) and solar creases were present; skin hyperex-
tensibility was absent. He had an asymmetric chest (Figure 
1i), long fingers and toes (Figure 1l,m), hallux valgus, and 
plantar subluxation of the metatarsophalangeal joint of the 
halluces, as well as prominent calcaneus (Figure 1m). He 
developed multiple joint contractures resulting in reduced 
ankle dorsiflexion, hip flexion, elbow extension, and wrist 
dorsiflexion.
3 |  MOLECULAR INVESTIGATION
Sanger sequencing of CHST14 and DSE was performed for 
patient 1 based on clinical suspicion of mcEDS. No patho-
genic variants were detected in CHST14; a homozygous 
nonsense variant was identified in DSE (NM_013352.4, 
c.960T>A, p.(Tyr320*)) (Figure 2a). For patient 2, whole 
exome sequencing was performed (Data S1; Miyake, 
Tsurusaki, & Koshimizu, 2016) and a homozygous frameshift 
variant was identified in DSE (NM_013352.4, c.996dupT, 
p.(Val333Cysfs*4)); patient 3 exhibited homozygosity for 
this variant, whereas their parents exhibited heterozygosity 
(Figure 2a). None of the identified DSE variants were reg-
istered in ExAC, Exome Variant Server, or Human Genetic 
Variant Database.
4 |  GLYCOBIOLOGICAL 
ANALYSIS
Disaccharide compositions of DS and chondroitin sulfate 
(CS) chains in urine samples from patient 1 and an age-
matched healthy man were analyzed as described previ-
ously (Data S2; Mizumoto, Kosho, & Hatamochi, 2017). 
DS disaccharide was not detected in the urine of patient 
1, whereas it was present in the urine of the age-matched 
healthy man (Figure S1; Table S1A). In contrast, the 
amount of CS disaccharides in the urine was similar be-
tween patient 1 and the age-matched healthy man (Figure 
S1; Table S1B).
5 |  DISCUSSION
We presented three patients with mcEDS-DSE from two new 
families. Clinical and molecular features of the five previously 
reported patients (Müller et al., 2013; Schirwani et al., 2019; 
F I G U R E  2  Molecular investigation. 
(a) Pedigree information and intrafamilial 
segregation of detected variants in DSE. 
(b) cDNA structure of DSE and pathogenic 
variants (mcEDS-DSE). Untranslated 
regions (UTRs) are shown as orange bars. 
The first base and each position of exon-
exon junctions in open reading frames 
(ORFs) are shown in light blue. Pathogenic 
variants reported in this study are shown in 
red characters. ex: exon



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 of 11 |   LAUTRUP eT AL.
Syx et al., 2015), including additional information of the sis-
ters reported by Syx et al. (2015) and the three patients in this 
series are reviewed in Table 1. Truncating variants in DSE 
were identified in the three current patients, whereas previ-
ously detected variants were missense in three families and a 
frameshift variant in one family. Significant reduction or loss 
of epimerase activity and a marked reduction in DS disaccha-
rides were demonstrated in the patient with p.(Ser268Leu) 
(Müller et al., 2013). A minor fraction of DS was detected 
as the glycosaminoglycan component of decorin in the pa-
tient with p.(Arg267Gly) (Syx et al., 2015). The preservation 
of DS moieties in mcEDS-DSE, in contrast to the complete 
loss of DS in mcEDS-CHST14 (Dündar, Müller, & Zhang, 
2009; Miyake, Kosho, & Mizumoto, 2010), suggested the 
residual activity of mutant DSE or partially compensating 
activity of dermatan sulfate epimerase-like protein (encoded 
by DSEL) (Syx et al., 2015). The measurement of the disac-
charide compositions of DS and CS chains in a urine sample 
is a recently established non-invasive method to screen for 
mcEDS-CHST14 through the assessment of DS biosynthesis 
(Mizumoto et al., 2017). The lack of DS in the urine sample 
from patient 1 in this study suggests that this test may also be 
useful for screening of mcEDS-DSE.
Frequent (affecting at least three patients) craniofacial 
and skeletal features in mcEDS-DSE are shown in Table 1. 
Two reported patients (Schirwani et al., 2019; Syx et al., 
2015) and patient 2 in the present report had joint pain. 
Frequent skin, vascular, ocular, nervous, and muscle fea-
tures are also shown in Table 1. Even though the number 
of patients with mcEDS-DSE is small and an accurate fre-
quency of each feature in patients with mcEDS-CHST14 
is unavailable, the general patterns of symptoms seem to 
be similar between the two subtypes. However, several 
patients with mcEDS-CHST14 had life-threatening com-
plications (e.g., infectious endocarditis, Kono et al., 2016; 
Kosho, Miyake, & Hatamochi, 2010, fulminant gastric 
ulcer, Kosho et al., 2010; diverticular perforation, Kosho 
et al., 2010; Mochida, Amano, & Miyake, 2016), and five 
patients died (Dündar, Kurtoglu, & Elmas, 2001; Janecke, 
Li, & Boehm, 2016). No such serious complication has 
yet been observed in patients with mcEDS-DSE. Syx et al. 
(2015) hypothesized that the residual availability of some 
DS structures, including iduronic acid-containing disac-
charide units, might contribute to an attenuated phenotype.
In conclusion, mcEDS-DSE constitutes a multisystem 
disorder with congenital and progressive features, as well as 
the depletion of DS, similar to mcEDS-CHST14. However, 
symptoms tend to be milder in patients with mcEDS-DSE.
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